The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

Aging and chronic diseases involve the gradual accumulation of subtle tissue changes over a long period. Therefore, there are ...

Discover a recent study where the authors propose a strategic push to double the diagnostic rate of at-risk MASH by 2030.

The report in JAMA Network Open noted that the pandemic "further exacerbated these trends." Also in the news: recalls due to fungal contamination and mold, climate disasters and their effects on ...

Once considered a niche concern, it is now a growing global epidemic affecting more than one in four adults worldwide.

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Gary Miller remembers being told by a [former] doctor that his fatty liver disease was a “benign condition.”“This doctor ...

The U.S. death rate from alcohol-related liver disease roughly doubled over two decades and was exacerbated by the pandemic, ...

Fatty liver disease, also known as MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), is estimated to affect up to 1 in 5 people in the UK [i]. The main risk factors are being ...

Simultaneous bariatric surgery and liver transplant for patients who are severely obese is safe and improves long-term health ...